NFKB1 and steatosis: IRF3 is proved to alleviate the lipid accumulation and to improve IR in the liver, and IRF9 can be used to ameliorate steatosis and inflammation.137, 138, 139, 140, 141 NF‐κB and its regulator IκB kinases (IKKs) are implicated in inflammatory responses and metabolism.